New study demonstrates the efficacy of a promising celiac disease drug at the molecular level." ScienceDaily. ScienceDaily, 24 June 2024. <www.sciencedaily.comTampere University. . New study demonstrates the efficacy of a promising celiac disease drug at the molecular level.
Celiac disease is a chronic autoimmune condition that occurs in around one per cent of the world's population. It is triggered by the consumption of gluten proteins from wheat, barley, rye and ... People with celiac disease have increased risk of dying prematurely, despite increased awareness of the disease in recent years and better access to gluten-free food. Celiac disease was linked to ...
Celiac disease affects 0.3-2.4% of people in most countries world-wide, and approx. 2% in Finland. Celiac patients suffer from a variety of symptoms, typically intestinal complaints, such as ... Distinct markers in the blood of people with celiac disease have been detected within a few hours of gluten being consumed. The findings address a longstanding mystery about what drives the adverse ...